- Report
- May 2024
- 138 Pages
Global
From €6214EUR$6,499USD£5,201GBP
- Report
- June 2024
- 200 Pages
Global
From €7601EUR$7,950USD£6,363GBP
- Report
- January 2022
- 60 Pages
Global
From €3777EUR$3,950USD£3,161GBP
- Clinical Trials
- April 2024
- 75 Pages
Global
From €1434EUR$1,500USD£1,200GBP
Brain hemorrhage drugs are a type of central nervous system (CNS) drug used to treat bleeding in the brain. These drugs are typically administered intravenously and work by reducing the pressure in the brain, which helps to stop the bleeding. They can also be used to reduce the risk of further bleeding and to reduce the risk of stroke. Common side effects of brain hemorrhage drugs include headache, nausea, and dizziness.
Brain hemorrhage drugs are used to treat a variety of conditions, including aneurysms, arteriovenous malformations, and subarachnoid hemorrhages. They are also used to treat traumatic brain injuries, such as those caused by a car accident or a fall.
The brain hemorrhage drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, and Sanofi. Other companies in the market include GlaxoSmithKline, AstraZeneca, and Johnson & Johnson. Show Less Read more